The “paediatric extension” encourages the development and availability of medicines for children by extending the term of protection of a patent by six months.
Worldwide, there are not enough safe, high-quality medicinal products that have been especially developed or adapted for children. A “paediatric extension” remedies this problem. Those contributing to the research and development of new medicines for children are granted a six-month extension of patent protection. This amendment to the patent law is a result of the ongoing revision of the Therapeutic Products Act. However, the date of its entry into force has not yet been determined.
A paediatric extension is possible:
- by extending an already granted supplementary protection certificate (SPC) by six months; or
- Through the new paediatric supplementary protection certificate, which is linked directly to the term of the patent and is also valid for six months.
Whoever applies for a paediatric extension must conduct clinical studies on children that comply with the paediatric investigation plan for the authorisation of a medicine. In addition, the study results must be publicly available in the information on the medicinal product, and the application for authorisation in Switzerland must be submitted no later than six months after the application for authorisation in the European Economic Area.
- In January 2007, the European Regulation on Medicinal Products for Paediatric Use came into force. Its objective is to authorise and put on the market more medicinal products for paediatric use. In Switzerland too, children should be better provided for with medicinal products which are tailored for them. For this purpose, a partial revision of the Patents Act (PatA) should be carried out within the scope of the revision of the Therapeutic Products Act (TPA). This provides for the introduction of a paediatric extension of a SPC.
- In May 2014, the new paediatric SPC is introduced within the scope of the parliamentary discussions on the ordinary revision of the TPA.
- On 18 March 2016, the Parliament adopts the ordinary revision of the TPA including the partial revision of the PatA (under “Amendment of other legislative instruments”).
- The IPI drafts the implementing provisions for the paediatric extension.
- On 22 June 2017, the partial revision of the Patents Ordinance is put to consultation. The consultation period ends on 20 October 2017.
Please refer to the German, French or Italian page for the official documents, as translated below.
- Media release of 22 June 2017
- Draft Patents Ordinance
- Explanatory report
- Accompanying communication to the cantons
- Accompanying communication to the organisations
- Recipient list
- Form for drafting comments
06.07.2018 | IPI
The founding of the sic! Foundation for intellectual property, information and competition law.
08.06.2018 | IP news
Winners of the European Inventor Award 2018 announced: The Swiss physicist Ursula Keller receives lifetime achievement award
Info event on using strategic patent analyses on 11.4.2018 in Zurich
14.02.2018 | Event
Stakeholder Discussions on: Innovation, availability and affordability of medical products. Can we achieve it all?
Séminaire IPI / LES: «développements récents en droit des marques», jeudi le 9 novembre 2017 au Novotel Genève
Patents and pharmaceuticals - Public event at the IPI in collaboration with the European Patent Office